中国畜牧兽医 ›› 2025, Vol. 52 ›› Issue (6): 2851-2864.doi: 10.16431/j.cnki.1671-7236.2025.06.037

• 基础兽医 • 上一篇    下一篇

UPLC-Q-TOF-MS结合网络药理学探讨威灵仙水提物抗炎的药效物质及作用机制

陈海燕, 张景正, 许晨新, 刘元芬, 周咏梅, 韩瑾   

  1. 江苏卫生健康职业学院药学院, 南京 211800
  • 收稿日期:2024-11-04 发布日期:2025-05-27
  • 通讯作者: 张景正 E-mail:zjingzlove@163.com
  • 作者简介:陈海燕,E-mail:chenhaiyan2128@126.com。
  • 基金资助:
    江苏省高职院校青年教师企业实践培训项目(2023QYSJ042);江苏省大学生创新创业训练计划项目(G-2023-0802);江苏卫生健康职业学院校级课题面上项目(JKC202406);2020年江苏省中青年学术带头人培养对象项目(苏教师函〔2020〕10号)

Exploration of the Pharmacodynamic Substances of Anti-inflammatory and Mechanism of Clematidis Radix Decoction Using UPLC-Q-TOF-MS Combined with Network Pharmacology

CHEN Haiyan, ZHANG Jingzheng, XU Chenxin, LIU Yuanfen, ZHOU Yongmei, HAN Jin   

  1. College of Pharmacy, Jiangsu Health Vocational College, Nanjing 211800, China
  • Received:2024-11-04 Published:2025-05-27

摘要: 【目的】利用超高效液相色谱-飞行时间质谱(UPLC-Q-TOF-MS)技术分析威灵仙水提物的主要化学成分,并结合网络药理学和细胞试验验证其抗炎作用机制。【方法】通过UPLC-Q-TOF-MS技术分析鉴定威灵仙水提物化学成分,结合网络药理学方法预测主要成分及相应靶点,并构建“成分-靶点-通路”网络,进一步利用AutoDock软件对主要活性成分与核心靶点进行分子对接,验证核心成分与关键靶点之间的结合能力。采用脂多糖(LPS)诱导RAW264.7细胞构建炎症模型,进行核心靶点和通路的验证。【结果】从威灵仙水提物中共鉴定出19个成分,其中酚酸类8个、皂苷类11个。网络药理学分析筛选出5个主要活性成分,主要通过调控磷脂酰肌醇3-激酶催化亚单位α(PIK3CA)、信号转导与转录激活子3(STAT3)、磷脂酰肌醇3-激酶催化亚单位β(PIK3CB)、肿瘤坏死因子(TNF)等核心靶点,并通过介导PI3K/Akt/STAT3等关键信号通路发挥抗炎作用。ELISA试验结果显示,与对照组相比,模型组细胞炎症因子TNF-α、白细胞介素-6(IL-6)、IL-1β含量显著升高(P<0.05);与模型组相比,威灵仙水提物各剂量组细胞中TNF-α、IL-6、IL-1β含量显著降低(P<0.05)。Western blotting结果显示,与对照组相比,模型组细胞中PI3K、p-PI3K、Akt、p-Akt蛋白表达量显著上调(P<0.05);与模型组相比,威灵仙水提物各剂量组p-PI3K、p-Akt蛋白表达量均显著下调(P<0.05)。【结论】威灵仙可通过多成分、多靶点、多途径发挥抗炎作用,且作用靶点与PI3K/Akt信号通路有关。本研究结果为深入研究威灵仙的药效物质基础及药理活性提供了参考。

关键词: 威灵仙; UPLC-Q-TOF-MS; 网络药理学; 抗炎; 炎性因子

Abstract: 【Objective】 This study aimed to analyze the main chemical components of Clematidis Radix decoction by ultra performance liquid chromatography with time-of-flight mass spectrometry (UPLC-Q-TOF-MS),and verify its anti-inflammatory mechanism by combining network pharmacology and cellular experiments.【Method】 The chemical composition of Clematidis Radix decoction was analyzed and identified by UPLC-Q-TOF-MS,the main components and corresponding targets were predicted by network pharmacology method,and the "component-target-pathway" network was constructed.The molecular docking between the main active ingredients and the core targets was carried out by AutoDock software to verify the binding ability between the core components and the key targets.The inflammation model of RAW264.7 cells was constructed by lipopolysaccharide (LPS) induction,and the core target and pathway were verified.【Result】 A total of 19 components were identified from Clematidis Radix decoction,including 8 phenolic acids and 11 saponins.Network pharmacological analysis screened 5 main active ingredients mainly modulating the PI3K/Akt/STAT3 signaling pathway mediated by core targets including phosphatidylinositol 3-kinase catalytic subunit α (PIK3CA),signal transduction and transcriptional activator 3 (STAT3),phosphatidylinositol 3-kinase catalytic subunit β (PIK3CB),and tumor necrosis factor (TNF) to exert anti-inflammatory effects.ELISA test results showed that compared with control group,the contents of inflammatory cytokines TNF-α,interleukin-6 (IL-6) and IL-1β in model group were significantly increased (P<0.05).Compared with model group,the contents of TNF-α,IL-6 and IL-1β in each dose group of Clematidis Radix decoction were significantly decreased (P<0.05). Western blotting results showed that compared with control group,the protein expressions of PI3K,p-PI3K,Akt and p-Akt in model group were significantly up-regulated (P<0.05).Compared with model group,the expression levels of p-PI3K and p-Akt were significantly decreased in each dose group of Clematidis Radix decoction (P<0.05). 【Conclusion】 Clematidis Radix could exert anti-inflammatory effects through multi-component,multi-target and multi-pathway,and the target was related to PI3K/Akt signaling pathway.The results of this study provided a reference for further study of the pharmacological material basis and pharmacological activity of Clematidis Radix.

Key words: Clematidis Radix; UPLC-Q-TOF-MS; network pharmacology; anti-inflammatory; inflammatory factor

中图分类号: